- New treatment options revise the prognosis for keratoconus
- Take-home message: Understanding of keratoconus and the resulting dramatic changes in management in recent years have given rise to treatment paradigms that would have been unrecognizable to ophthalmologists a generation ago. The new landscape ...
- Cost effectiveness of collagen crosslinking for progressive keratoconus in the
- Deterministic sensitivity analysis shows that this could rise above £33 263 per QALY if the duration of treatment efficacy is limited to 5 years. Other model parameters are not decision significant.
- DME treatment plan should be customized for each patient
- The classic ocular treatment for DME, going back to the 1985 Early Treatment Diabetic Retinopathy Study, was focal or grid photocoagulation. In 2012, Lucentis (ranibizumab, Genentech) achieved FDA approval for the treatment of DME, and in 2014, Eylea ...
- Espina: Kapwa's 'Pangga-a Sab ko'
- Dr. Yong's mission. Jason, a 12-year-old boy from Bohol, was diagnosed to have keratoconus for both eyes.
Keratoconus Prognosis is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Keratoconus Prognosis books and related discussion.
Suggested News Resources
Great care has been taken to prepare the information on this page. Elements of the content come from factual and lexical knowledge databases, realmagick.com library and third-party sources. We appreciate your suggestions and comments on further improvements of the site.